Nara Tae

440 total citations
14 papers, 351 citations indexed

About

Nara Tae is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nara Tae has authored 14 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nara Tae's work include CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Natural product bioactivities and synthesis (3 papers). Nara Tae is often cited by papers focused on CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Natural product bioactivities and synthesis (3 papers). Nara Tae collaborates with scholars based in South Korea and Vietnam. Nara Tae's co-authors include Jeong‐Hyung Lee, Byung Sun Min, Su-Hyun Lee, Ok Kyu Park, Cheol Hwangbo, Jinwoong Kim, Ju Hee Lee, Van Thu Nguyen, Jung Joon Lee and Sungwoo Ryoo and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and European Journal of Pharmacology.

In The Last Decade

Nara Tae

14 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nara Tae South Korea 11 196 82 55 53 42 14 351
Kuei-Li Lin Taiwan 12 284 1.4× 64 0.8× 31 0.6× 119 2.2× 60 1.4× 13 503
Tithi Roy United States 7 172 0.9× 45 0.5× 78 1.4× 52 1.0× 37 0.9× 17 392
Hanchi Miao China 7 234 1.2× 63 0.8× 49 0.9× 48 0.9× 39 0.9× 7 345
Xinxian Weng China 9 165 0.8× 83 1.0× 51 0.9× 97 1.8× 53 1.3× 14 306
Yanmin Dong China 13 337 1.7× 53 0.6× 29 0.5× 81 1.5× 58 1.4× 19 617
Fu‐Gang Duan China 10 219 1.1× 45 0.5× 46 0.8× 52 1.0× 80 1.9× 14 390
Sergette Banang‐Mbeumi United States 6 160 0.8× 45 0.5× 76 1.4× 52 1.0× 36 0.9× 9 356
Jianyong Xiao China 15 370 1.9× 41 0.5× 56 1.0× 91 1.7× 114 2.7× 26 560
Yuhui Tan China 11 236 1.2× 33 0.4× 39 0.7× 46 0.9× 52 1.2× 20 363

Countries citing papers authored by Nara Tae

Since Specialization
Citations

This map shows the geographic impact of Nara Tae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nara Tae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nara Tae more than expected).

Fields of papers citing papers by Nara Tae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nara Tae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nara Tae. The network helps show where Nara Tae may publish in the future.

Co-authorship network of co-authors of Nara Tae

This figure shows the co-authorship network connecting the top 25 collaborators of Nara Tae. A scholar is included among the top collaborators of Nara Tae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nara Tae. Nara Tae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Cho, Jaewon, Nara Tae, Seung‐Joo Lee, et al.. (2024). The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells. Cancer Immunology Immunotherapy. 73(10). 196–196. 5 indexed citations
2.
Tae, Nara, et al.. (2022). Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody. Immune Network. 22(1). e4–e4. 25 indexed citations
3.
Cho, Jaewon, et al.. (2022). Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy. Biomolecules & Therapeutics. 30(5). 418–426. 5 indexed citations
4.
Kim, Min Jung, et al.. (2020). Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells. International Journal of Molecular Sciences. 21(9). 3258–3258. 17 indexed citations
5.
Kim, Min Jung, et al.. (2020). BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody. Viruses. 12(6). 684–684. 11 indexed citations
6.
Tae, Nara, et al.. (2017). Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells. Oncotarget. 8(24). 38886–38901. 22 indexed citations
7.
Tae, Nara, Trần Mạnh Hưng, Nam‐Ho Kim, et al.. (2017). A cassaine diterpene alkaloid, 3β-acetyl-nor-erythrophlamide, suppresses VEGF-induced angiogenesis and tumor growth via inhibiting eNOS activation. Oncotarget. 8(54). 92346–92358. 13 indexed citations
9.
Nguyen, Van Thu, Nara Tae, Su-Hyun Lee, et al.. (2014). Anti-inflammatory and heme oxygenase-1 inducing activities of lanostane triterpenes isolated from mushroom Ganoderma lucidum in RAW264.7 cells. Toxicology and Applied Pharmacology. 280(3). 434–442. 53 indexed citations
10.
Kim, Jun-Hyeong, et al.. (2014). The anti-inflammatory effect of 3-deoxysappanchalcone is mediated by inducing heme oxygenase-1 via activating the AKT/mTOR pathway in murine macrophages. International Immunopharmacology. 22(2). 420–426. 33 indexed citations
11.
Hưng, Trần Mạnh, To Dao Cuong, Jeong Ah Kim, et al.. (2013). Cassaine diterpene alkaloids from Erythrophleum fordii and their anti-angiogenic effect. Bioorganic & Medicinal Chemistry Letters. 24(1). 168–172. 18 indexed citations
12.
Tae, Nara, et al.. (2012). Malabaricone C suppresses lipopolysaccharide-induced inflammatory responses via inhibiting ROS-mediated Akt/IKK/NF-κB signaling in murine macrophages. International Immunopharmacology. 14(3). 302–310. 31 indexed citations
13.
Tae, Nara, et al.. (2011). 3-Oxoolean-12-en-27-oic acid inhibits the proliferation of non-small cell lung carcinoma cells by inducing cell-cycle arrest at G0/G1 phase.. PubMed. 31(6). 2179–85. 2 indexed citations
14.
Lee, Jong‐Kyu, Nara Tae, Jung Joon Lee, Taeho Kim, & Jeong‐Hyung Lee. (2010). Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264.7 cells by inducing proteasomal degradation of TRAF6. European Journal of Pharmacology. 636(1-3). 173–180. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026